TScan Therapeutics, Inc. TCRX Q2 2026 earnings

FAQ

When did TScan Therapeutics, Inc. report Q2 2026 earnings?

TScan Therapeutics, Inc. (TCRX) reported Q2 2026 earnings on August 12, 2026 before market open.

What were TScan Therapeutics, Inc.'s Q2 2026 revenue and EPS?

TScan Therapeutics, Inc. reported revenue of $1.1M and eps of $-0.23 for Q2 2026.

Did TScan Therapeutics, Inc. beat estimates in Q2 2026?

Revenue missed the consensus estimate of $1.9M by $824.0K. EPS beat the consensus estimate of $-0.25 by $0.02.

How did TScan Therapeutics, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 65.8% from $3.1M a year earlier and eps grew 17.9% from $-0.28.

Where can I find TScan Therapeutics, Inc.'s Q2 2026 SEC filings?

You can read the 8-K earnings release (0001193125-26-345732) and the 10-Q periodic report (0001193125-26-345749) directly on SEC EDGAR. The filing index links above go to sec.gov.